definiens: means all Patents [COMPANY] Controls during the Term that Cover [COMPANY] Platform Technology, includingAdimab Platform Technology Improvements . ( For clarity, [COMPANY] Platform Patents exclude Program Antibody Patents.)1.9 means ( a ) the discovery and optimization of antibodies via methods that include [ * * * ], ( b ) allmethods, materials and other Know - How used in the foregoing, including in silico, data - driven and machine learning analyses and(c ) platforms embodying, components, component steps and other portions of any of the foregoing in ( a ) or ( b ) ; in each case, solely to theextent the foregoing either ( i ) are Covered by Patents Controlled by [COMPANY] or ( ii ) constitute Confidential Information of [COMPANY] . For clarity, [COMPANY] Platform Technology excludes Program Antibodies but includes technology used in the discovery and optimization of any ProgramAntibody, in each case not based on the specific composition of such Program Antibody ( or any product containing a Program Antibody ), butbased instead on the manner in which such Program Antibody was discovered or optimized under a Research Program . [COMPANY] PlatformTechnology includes [COMPANY] Platform Technology Improvements